242 related articles for article (PubMed ID: 2297698)
1. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
Mayer LD; Bally MB; Loughrey H; Masin D; Cullis PR
Cancer Res; 1990 Feb; 50(3):575-9. PubMed ID: 2297698
[TBL] [Abstract][Full Text] [Related]
2. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Mayer LD; Tai LC; Ko DS; Masin D; Ginsberg RS; Cullis PR; Bally MB
Cancer Res; 1989 Nov; 49(21):5922-30. PubMed ID: 2790807
[TBL] [Abstract][Full Text] [Related]
3. Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
Boman NL; Masin D; Mayer LD; Cullis PR; Bally MB
Cancer Res; 1994 Jun; 54(11):2830-3. PubMed ID: 8187061
[TBL] [Abstract][Full Text] [Related]
4. Reduced toxicity and enhanced antitumor effects in mice of the ionophoric drug valinomycin when incorporated in liposomes.
Daoud SS; Juliano RL
Cancer Res; 1986 Nov; 46(11):5518-23. PubMed ID: 3756900
[TBL] [Abstract][Full Text] [Related]
5. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
Mayer LD; Nayar R; Thies RL; Boman NL; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1993; 33(1):17-24. PubMed ID: 8269584
[TBL] [Abstract][Full Text] [Related]
6. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
Lim HJ; Masin D; Madden TD; Bally MB
J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.
Perez-Soler R; Khokhar AR
Cancer Res; 1992 Nov; 52(22):6341-7. PubMed ID: 1423280
[TBL] [Abstract][Full Text] [Related]
8. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
Tardi P; Choice E; Masin D; Redelmeier T; Bally M; Madden TD
Cancer Res; 2000 Jul; 60(13):3389-93. PubMed ID: 10910044
[TBL] [Abstract][Full Text] [Related]
9. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
Ganu UK; Khandalekar DD; Gokhale SV
Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
Webb MS; Harasym TO; Masin D; Bally MB; Mayer LD
Br J Cancer; 1995 Oct; 72(4):896-904. PubMed ID: 7547237
[TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
[TBL] [Abstract][Full Text] [Related]
12. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
Rahman A; White G; More N; Schein PS
Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
15. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
Mayer LD; Dougherty G; Harasym TO; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
[TBL] [Abstract][Full Text] [Related]
17. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
Mayer LD; Tai LC; Bally MB; Mitilenes GN; Ginsberg RS; Cullis PR
Biochim Biophys Acta; 1990 Jun; 1025(2):143-51. PubMed ID: 2364073
[TBL] [Abstract][Full Text] [Related]
18. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
Inaba M; Maruyama E
Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
[TBL] [Abstract][Full Text] [Related]
19. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
Mayer LD; St-Onge G
Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
[TBL] [Abstract][Full Text] [Related]
20. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
